HALEOS LABS
Back to Balance Sheet
|
HALEOS LABS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹151 Cr | ₹149 Cr | ₹137 Cr | ₹143 Cr | ₹119 Cr |
What is the latest Total Current Liabilities ratio of HALEOS LABS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹151 Cr |
| Mar2024 | ₹149 Cr |
| Mar2023 | ₹137 Cr |
| Mar2022 | ₹143 Cr |
| Mar2021 | ₹119 Cr |
How is Total Current Liabilities of HALEOS LABS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹151 Cr | 1.52 | |
| Mar2024 | ₹149 Cr | 8.57 | |
| Mar2023 | ₹137 Cr | -4.19 | |
| Mar2022 | ₹143 Cr | 20.46 | |
| Mar2021 | ₹119 Cr | - | |
Compare Total Current Liabilities of peers of HALEOS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HALEOS LABS | ₹474.9 Cr | 4% | 16.4% | 15.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,270.0 Cr | -1.4% | 2.4% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹222,224.0 Cr | 12.2% | 23.1% | 21.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,325.0 Cr | 2.4% | 5.3% | 41.7% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | 1.7% | 0.7% | -3.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,876.6 Cr | 3% | -14.9% | -10.2% | Stock Analytics | |
HALEOS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HALEOS LABS | 4% |
16.4% |
15.9% |
| SENSEX | 2.2% |
0.9% |
-3.7% |
You may also like the below Video Courses